Chicago USA 18 - 22 April 2026

American Academy of Neurology Annual Meeting (AAN 2026)

Presentation schedule and materials
Sunday, 19 April 2026
14:24  - 14:36
CST
ORAL PRESENTATION
Effects of Semaglutide on Alzheimer’s Disease-Related Biological Processes: Results from a Biofluid Biomarker and Multiomics Immunophenotyping Phase 3 Study in Patients with Early Alzheimer’s Disease After 12 Weeks of Treatment
Kristian Frederiksen1; Paul Mystkowski2; Marie Bentsen3; Dylan Belmont-Rausch3; Lisbeth Carstensen3; Brian Cutler4; Redwan Farooq4; Lea Hildebrandt3; Martí Jiménez-Mausbach3;  Peter Johannsen3;  Gabriel Martino3;  Joseph Polex-Wolf3;  Amaya Zaratiegui3;  Giovanni B. Frisoni5;  Kate Attfield4;  Lotte Knudsen3
MATERIALS AVAILABLE
aan-2026-biofluid-biomarker-oral-pressentation
Slide
17:00  - 18:00
CST
#012
POSTER
Semaglutide Concentration in Cerebrospinal Fluid from Patients with Early Alzheimer’s Disease After 12 Weeks of Subcutaneous Treatment
Susan Alford1; Peter Johannsen2; Marie Bentsen2; Dylan Belmont Rausch2; Lisbeth Carstensen2; Rose Jeppesen2; Gabriel Martino2; Martí Jiménez-Mausbach2; Lotte Knudsen2
MATERIALS AVAILABLE
aan-2026-sema-csf-study-poster
Poster
Monday, 20 April 2026
17:00  - 18:00
CST
#006
POSTER
Results from evoke and evoke+: Two phase 3, randomised, placebo-controlled trials of semaglutide in participants with early-stage symptomatic Alzheimer’s disease
Jeffrey L. Cummings1, Alireza Atri2–4, Howard H. Feldman5, Mary Sano6,7, Henrik Zetterberg8, Filip K. Knop9, Peter Johannsen9, Teresa León9, Rikke Mortensen Abschneider9, Philip Scheltens10,11  
MATERIALS AVAILABLE
aan-2026-johannsen-evoke-plus-topline-results
Poster
17:00  - 18:00
CST
#007
POSTER
Semaglutide Impacts Proteomic Signatures Related to Dementia Risk in the SELECT Cardiovascular Outcomes Trial
Dylan Belmont-Rausch1, MartíJiménezMausbach1, JanChristianRefsgaard1,GabrielMartino1,TeresaLeonColombo1,BettyTijms2,ClarePaterson3  
MATERIALS AVAILABLE
aan-2026-belmont-rausch-select-ad-ctad25-poster
Poster
Tuesday, 21 April 2026
08:00  - 09:00
CST
#009
POSTER
Early Alzheimer's Disease Diagnosis and Blood Biomarkers: Primary Care Physician Attitudes, Perceptions and Barriers in the USA
Susan Alford1; Sheena K. Aurora2; Justine Coppinger2; Marti Jimenez-Mausbach3; Rosemary D. Laird4; Hemant Pandey5; Sutapa Ray2; Jeffrey M. Burns6
MATERIALS AVAILABLE
aan-2026-c2n-study-poster
Poster
17:00  - 18:00
CST
#002
POSTER
Medication Adherence and Cost of Care for Comorbid Conditions in Patients with Early Alzheimer's Disease: A Retrospective Cohort Study Using the Axon Registry and Claims Data
Lei Lv1; Abdalla Aly1; Caroline McKay1; Paul Mystkowski1; Shannon Gallagher2; Kristian Garcia2; Heather E. Moss3; Soeren Mattke4
MATERIALS AVAILABLE
aan-2026-adherent-study-poster
Poster
Keywords
Neurology
AAN